/

/

CJC-1295 (No DAC) + Ipamorelin

CJC-1295 (No DAC) + Ipamorelin

Peptide, Muscle Growth & Performance

/

/

CJC-1295 (No DAC) + Ipamorelin

CJC-1295 (No DAC) + Ipamorelin

Peptide, Muscle Growth & Performance

CJC-1295 (No DAC) + Ipamorelin

Order Now, Ships Today

$76.95

One-time

Bulk deal
QuantityDiscountDiscounted price
3 - 45%$73.10
5 - 67%$71.56
7 - 89%$70.02
9 +11%$68.49

Research Use Only

These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.

What is it?

CJC-1295 + Ipamorelin is a combination of two research peptides — one that supports growth hormone–releasing hormone (GHRH) activity, and another that promotes growth hormone (GH) release through pituitary signaling. Researchers study this blend for its potential role in supporting cellular recovery, lean tissue development, and metabolic balance in controlled laboratory settings.

Certificate of Analysis

This research peptide blend is tested for 99%+ purity. COA: CJC-1295 + Ipamorelin (5mg + 5mg)

Frequently Asked Questions

Does the product come with instructions?

Products from Elite Miami Peptides do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.

Each vial contains exactly what’s indicated on the label. For instance, a 10mg vial contains precisely 10mg of lyophilized peptide. Researchers may divide it into smaller research portions—such as four 2.5mg aliquots—but the total content remains the same.

Yes. All peptides are supplied in lyophilized powder form and do not come reconstituted. Any extra materials required for research, such as solvents or diluents, must be obtained separately.

When stored as a dry powder, peptides remain stable for up to 2 years.
Once reconstituted, the solution should be kept refrigerated and is typically stable for up to 2 months under proper storage conditions.

Overview

The CJC-1295 + Ipamorelin blend is often studied for its potential to synergistically enhance growth hormone secretion through distinct pathways — GHRH receptor activation (CJC-1295) and ghrelin receptor stimulation (Ipamorelin). When combined, these peptides are believed to complement each other’s signaling effects, creating a longer and more sustained GH pulse in experimental models. Research has focused on their impact on cellular repair, protein synthesis, and recovery-related mechanisms.

Explanation

This combo may help the body release more growth hormone. Each peptide triggers it in a different way. Together they can create a stronger and longer boost. Studies look at how this could support better cell repair, muscle building, and recovery.

⚠️ Disclaimer: this product is not approved for medical use and is not intended to diagnose, treat, or prevent any disease. All information provided is for educational and research purposes only, and this product must never be used in humans or animals.

History

The concept of the CJC-1295 + Ipamorelin blend stems from parallel developments in peptide research aimed at exploring growth hormone modulation. CJC-1295, a synthetic analog of growth hormone–releasing hormone (GHRH), was developed in the early 2000s to extend the half-life and activity of natural GHRH fragments for research into growth hormone and IGF-1 pathways. Meanwhile, Ipamorelin—a selective ghrelin receptor agonist—emerged from studies in the 1990s investigating ghrelin mimetics and their ability to stimulate growth hormone release with minimal off-target hormonal effects. Together, these peptides became of interest for laboratory research into growth hormone regulation, recovery, and metabolic processes. Svensson J. et al. (1998).

Structure

CJC-1295 Structure CAS #: 446036-97-1 Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂ Molecular Weight: 3367.9 g/mol PubChem ID: 91976842 Ipamorelin Structure CAS #: 170851-70-4 Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂ Molecular Weight: 3367.9 g/mol PubChem ID: 91976842

Research Findings

CJC-1295 and Ipamorelin have been examined in endocrine, metabolic, regenerative, and systemic models, with research exploring their influence on growth hormone pathways, body composition, tissue recovery, and cellular viability. Studies highlight their role in IGF-1 activity, repair processes, and systemic resilience in preclinical settings. Key Areas of Research: • Endocrine: Growth hormone, IGF-1, signaling • Metabolic: Lipids, lean tissue, glucose balance • Cellular: Proliferation, repair, recovery • Systemic: Cardiovascular, viability, healing Together, these findings suggest broad experimental potential for CJC-1295 and Ipamorelin across multiple biological pathways. By modulating growth hormone signaling, influencing metabolic activity, and supporting cellular and systemic recovery, this combination provides a versatile platform for research into regeneration, resilience, and physiological balance in laboratory models. Teichman S.L. et al., Journal of Clinical Endocrinology & Metabolism, 2006

Explanation

In simple terms, this combination is designed to mimic natural processes that trigger growth hormone release. Scientists are studying how this pairing could impact recovery, repair, and metabolism under laboratory conditions. It’s important to note that CJC-1295 + Ipamorelin is not for human use and must only be handled in research settings by trained professionals.

References

Te Teichman S.L. et al. (2006). Prolonged stimulation of GH and IGF-1 secretion by CJC-1295 in healthy adults. J Clin Endocrinol Metab, 91(3):799-805. Lapierre S.S. et al. (2006). Sustained GH and IGF-1 responses to CJC-1295 in GHRH knockout mice. Am J Physiol Endocrinol Metab, 291(2):E282-E287. Svensson J. et al. (1998). Ipamorelin selectively stimulates GH release without affecting cortisol or prolactin. J Clin Endocrinol Metab, 83(9):3094-3101. Culler M.D. et al. (2002). Pharmacological characterization of ipamorelin, a novel GHRP with GH selectivity. J Endocrinol, 174(2):R1-R6.

Other peptides

from $48.95

Need assistance? Text us now

Our specialists respond within minutes to any order or product inquiry.

Research Use Only

These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.

Text us now

By clicking the button above, you agree to receive marketing text messages from Elite Miami Peptides at the number provided. Consent is not a condition of purchase. Msg & data rates may apply. Reply STOP to cancel, HELP for help. View our Privacy Policy.

Research Use Only

All compounds from Elite Miami Peptides are intended strictly for laboratory research purposes.

They are not for human use, consumption, or therapeutic applications.
Products are supplied exclusively to qualified professionals working in compliance with all applicable laws and regulations.